Organ involvement in Argentinian systemic sclerosis patients with "late" pattern as compared to patients with "early/active" pattern by nailfold capillaroscopy

Clinical Rheumatology

Volumn 32, Issue 6, 2013, Pages 839-843

  Marino Claverie, Lucila ^a   Knobel, Elizabeth ^a   Takashima, Lorena ^a   Techera, Lorena ^a   Oliver, Marina ^a   Gonzalez, Paula ^a   Romanini, Félix E ^a   Fonseca, María L ^a   Mamani, Marta N ^a  

^a Hospital Bernardino Rivadavia   (Argentina)

Author keywords

Nailfold capillaroscopy; Scleroderma pattern; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSING CAPACITY FOR CARBON MONOXIDE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ESOPHAGUS MANOMETRY; FEMALE; FUNCTION TEST; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG VOLUME; MALE; NAILFOLD CAPILLAROSCOPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIX MINUTE WALK TEST; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

AGED; ARGENTINA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879205466     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2204-8     Document Type: Article

References (31)

1. LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin N Am 22:675-694
2. Steen VD, Medsger TA (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437-2444
3. Cutolo M, Sulli A, Pizzorini C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155-160
4. Derk CT, Jimenez SA (2003) Systemic sclerosis: current view of its pathogenesis. Autoimmun Rev 2(4):181-191
5. Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity 31(3):195-214
6. Sapadin AN, Esser AC, Fleischmajer R (2001) Immunopathogenesis of scleroderma-evolving concepts. Mt Sinai J Med 68(4-5):233-242
7. Riccieri V, Rinaldi T, Spadaro A et al (2003) Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol 22:102-106
8. Maricq HR, LeRoy EC (1973) Patterns of capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 16:619-628
9. De Angelis R, Grassi W, Cutolo M (2009) A growing need for capillaroscopy in rheumatology. Arthritis Rheum 61(3):405-410
10. Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28(5):496-501
11. Ingegnoli F, Boracchi P, Gualtierotti R et al (2008) Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum 58:2174-2182
12. Maricq HR (1981) Wide-field capillary microscopy. Arthritis Rheum 24:1159-1165
13. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023-3030
14. Hofstee A, Vonk Noordegraaf A, Voskuyl A et al (2009) Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 68:191-195
15. Sato LT, Kayser C, Andrade LE (2009) Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port 34(2A):219-227
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980). Arthritis Rheum 23(5):581-590
17. LeRoy EC, Black CM, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
18. Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A, Deschepper E, Cutolo M (2011) Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 70(1):180-183
19. Cutolo M, Pizzorni C, Tuccio M, Burroni A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43(6):719-726
20. Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 61(6):862-870
21. Caramaschi P, Canestrini S, Martinelli NP et al (2007) Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 46(10):1566-1569
22. Riccieri V, Germano V, Alessandri C et al (2008) More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol 26:992-997
23. Ostojic P, Damjanov N (2006) Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 25(4):453-478
24. Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31(2):286-294
25. Kim HS, Park MK, Kim HY et al (2010) Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 29(3):247-254
26. Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636-1639
27. Ong YY, Nikoloutsopoulos T, Bond CP et al (1998) Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. Asian Pac J Allergy Immunol 16(2-3):81-86
28. Sulli A, Pizzorni C, Smith V, Zampogna G, Ravera F, Cutolo M (2012) Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 64(3):821-825
29. Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183-1187
30. Nelson JL, Furst DE, Maloney S et al (1988) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559-562
31. Volpe A, Biasi D, Caramaschi P, Mantovani W, Bambara LM (2006) Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford) 45(3):314-320